YOUR GATEWAY TO INDONESIA AND SOUTHEAST ASIA
Search
xxx hd
Home News Item WuXi PharmaTech’s China-Based Small-Molecule Manufacturing Subsidiary, STA, Enters into Private Placement Agreement (WuXi PharmaTech (Cayman) Inc)
No image

WuXi PharmaTech’s China-Based Small-Molecule Manufacturing Subsidiary, STA, Enters into Private Placement Agreement (WuXi PharmaTech (Cayman) Inc)

juli 10, 2015by 0

Like

(Source: WuXi PharmaTech (Cayman) Inc) SHANGHAI, July 10, 2015 /PRNewswire/ — WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology, and medical device industries with operations in China and the United States, today announced that SynTheAll Pharmaceutical Co. Ltd. (STA), WuXi’s small-molecule manufacturing subsidiary, has entered into an agreement in connection with a planned private placement of 7,160,000 common shares of STA stock, representing approximately 6% of STA’s current shares outstanding, for RMB 498,694,000 in cash, or approximately $80 million at current exchange…

TAG
Previous Post Distribution of Aids and Assistive Devices for Persons with Disabilites (Ministry of Social Justice and Empowerment of the Republic of India)

Related articles

Geef een reactie

Het e-mailadres wordt niet gepubliceerd. Vereiste velden zijn gemarkeerd met *

Recent Posts

Popular